nVerses Capital’s Sight Sciences SGHT Stock Holding History

nVerses Capital’s Portfolio SGHT Stock Details SGHT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-1,300	Closed	-$8.67K	–	1354
2024 Q2	$8.67K	Buy	+1,300	New	+$7.69K	0.01%	917

Other funds holding SGHT

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

JSP

Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return

LFCM

Long Focus Capital Management San Juan, Puerto Rico $3.8B AUM 7.31% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

DSCM

Divisadero Street Capital Management Miami, Florida $2.39B AUM 134.55% 1-Year Est. Return

AMH

Apollo Management Holdings New York $7.6B AUM 23.97% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

nVerses Capital's SGHT Position: Q3 2024 in Review

nVerses Capital sold out of Sight Sciences (SGHT) in Q3 2024, closing a stake of 1,300 shares — an estimated $8.67K sold.

nVerses Capital first reported a position in SGHT in Q2 2024 and held it in 1 quarter. The position peaked at $8.67K in Q2 2024. 78 funds tracked by Wall St. Rank hold SGHT as of Q3 2024.

nVerses Capital reported no remaining Sight Sciences position as of Q3 2024 after selling out during the quarter.
nVerses Capital sold 1,300 Sight Sciences shares in Q3 2024, an estimated $8.67K.
nVerses Capital first reported a position in Sight Sciences in Q2 2024 and held it in 1 quarter.
nVerses Capital's Sight Sciences position peaked at $8.67K in Q2 2024.
78 funds tracked by Wall St. Rank held Sight Sciences as of Q3 2024.

Based on nVerses Capital's 13F filing for Q3 2024, filed 16 Oct 2024.